Pulse Biosciences (PLSE) shares were up 6.6% in Friday trading, a day after the company reported its Q2 results.
The company posted a Q2 net loss of $0.36 per diluted share, widening from a loss of $0.28 a year earlier.
Three analysts polled by FactSet expected a $0.36 loss.
Revenue for the quarter ended June 30 was $434,000.
Three analysts expected $500,000.
Pulse Biosciences said cash and cash equivalents totaled $101.6 million as of June 30.
Price: $40.76, Change: $+2.52, Percent Change: +6.58%